Liver Injury Patterns and Hepatic Toxicity among People Living with and without HIV and Attending Care in Urban Uganda

Introduction The evaluation of the patterns of liver injury, derived from liver chemistry panels, often may narrow on probable causes of the liver insult especially when coupled with clinical history, examination, and other diagnostic tests. Methods Among people living with and without HIV and attending care, we used the R ratio to evaluate for liver injury patterns. Liver injury patterns were defined as cholestatic (R < 2), mixed (R = 2‐5), and hepatocellular (R > 5). Results Overall, the proportions of participants with cholestatic liver injury, mixed liver injury, and hepatocellular liver injury were 55%, 34%, and 4%, respectively, with similar distribution when stratified by HIV status. Alcohol use among participants without HIV was associated with all patterns of liver injury (cholestatic liver injury (OR = 4.9 CI (1.0-24.2); p = 0.054), mixed liver injury (OR = 5.3 CI (1.1-27.3); p = 0.043), and hepatocellular liver injury (OR = 13.2 CI (1.0-167.3); p = 0.046)). Increasing age was associated with cholestatic liver injury among participants with HIV (OR = 2.3 CI (1.0-5.3); p = 0.038). Despite a high hepatitis B prevalence among participants with HIV, there was no association with liver injury. Conclusions Liver injury is prevalent among both people living with and without HIV in care, and cholestatic liver injury is the most common pattern. Alcohol is associated with all patterns of liver injury and increasing age associated with cholestatic liver injury among people living without HIV and people living with HIV, respectively.

[1]  H. Tola,et al.  Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study , 2021, HIV/AIDS.

[2]  Yun-li Wu,et al.  The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies , 2020, Epidemiology and Infection.

[3]  Manna Zhang,et al.  The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease. , 2020, Annals of hepatology.

[4]  G. Sebastiani,et al.  Clinical significance of elevated liver transaminases in HIV-infected patients. , 2019, AIDS.

[5]  R. Jha,et al.  Prevalence and Clinical Spectrum of Liver Disease in Nepalese HIV-Sero-Positive Patients Undergoing Antiretroviral Therapy: A Cross-Sectional Hospital Based Study , 2017, AIDS research and treatment.

[6]  Joaquín Sánchez,et al.  Interpretation of abnormal liver chemistries in the hospitalized patient , 2016, Clinical liver disease.

[7]  I. Schuppe-Koistinen,et al.  Evaluation of Patterns of Liver Toxicity in Patients on Antiretroviral and Anti-Tuberculosis Drugs: A Prospective Four Arm Observational Study in Ethiopian Patients , 2014, PloS one.

[8]  D. Spiegelman,et al.  Elevated alanine aminotransferase in antiretroviral‐naïve HIV‐infected African patients: magnitude and risk factors , 2012, HIV medicine.

[9]  A. Baranova,et al.  Non-Invasive markers for hepatic fibrosis , 2011, BMC gastroenterology.

[10]  E. Katabira,et al.  The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda. , 2008, African health sciences.

[11]  Stanley M. Cohen,et al.  ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries , 2017, The American Journal of Gastroenterology.

[12]  Michael P Holt,et al.  Drug-induced liver injury. , 2010, Handbook of experimental pharmacology.